International Validation of the Vascular Registry of Switzerland, Swissvasc: A VASCUNET Report.

IF 5.7 1区医学 Q1 PERIPHERAL VASCULAR DISEASE

European Journal of Vascular and Endovascular Surgery Pub Date : 2024-10-12 DOI:10.1016/j.ejvs.2024.10.016

Martin Altreuther, Matthew J Grima

{"title":"International Validation of the Vascular Registry of Switzerland, Swissvasc: A VASCUNET Report.","authors":"Martin Altreuther, Matthew J Grima","doi":"10.1016/j.ejvs.2024.10.016","DOIUrl":null,"url":null,"abstract":"Objective: Data validity and completeness is essential for registry data, and a meaningful interpretation of differences between countries can only be made if the data are robust within each of the countries. Therefore, the VASCUNET collaboration has performed validation of several vascular registries and has so far published the validation results of national vascular registries of Sweden, Denmark, and Malta. The findings of the validation of the Swissvasc Registry, the vascular registry of Switzerland, are presented here.Methods: Five of 34 hospitals participating in Swissvasc were visited by two international validators. Independent evaluation of the procedures of carotid endarterectomy, infrarenal abdominal aortic aneurysm (AAA) repair, and bypass surgery for lower extremity arterial disease (LEAD) was performed. Local administrative data and Swissvasc Registry data were compared for external validation, as well as registry data of 15 randomly picked cases within each group with data from individual patient records for internal validation.Results: Hospital administrative data identified 265 carotid, 399 AAA, and 399 LEAD procedures, whereas Swissvasc identified 265 carotid, 398 AAA, and 395 LEAD procedures. Four LEAD procedures were found in hospital administrative data but not in Swissvasc. External validity was 100% for carotids, 99.8% for AAA, and 99% for LEAD. In internal validation, 5.2% of the variable data were missing in Swissvasc, and 2.4% were different from data in patient records, resulting in external validity of 92.8% for carotids, 94.4% for AAA, and 90.1% for LEAD.Conclusion: The VASCUNET template was used for international validation of registry data, and demonstrated that Swissvasc is a reliable system of quality data collection for the participating vascular centres, with excellent external validity and good internal validity. Quality in the Swissvasc registry data was clearly superior to local administrative data.","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Vascular and Endovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejvs.2024.10.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Data validity and completeness is essential for registry data, and a meaningful interpretation of differences between countries can only be made if the data are robust within each of the countries. Therefore, the VASCUNET collaboration has performed validation of several vascular registries and has so far published the validation results of national vascular registries of Sweden, Denmark, and Malta. The findings of the validation of the Swissvasc Registry, the vascular registry of Switzerland, are presented here.

Methods: Five of 34 hospitals participating in Swissvasc were visited by two international validators. Independent evaluation of the procedures of carotid endarterectomy, infrarenal abdominal aortic aneurysm (AAA) repair, and bypass surgery for lower extremity arterial disease (LEAD) was performed. Local administrative data and Swissvasc Registry data were compared for external validation, as well as registry data of 15 randomly picked cases within each group with data from individual patient records for internal validation.

Results: Hospital administrative data identified 265 carotid, 399 AAA, and 399 LEAD procedures, whereas Swissvasc identified 265 carotid, 398 AAA, and 395 LEAD procedures. Four LEAD procedures were found in hospital administrative data but not in Swissvasc. External validity was 100% for carotids, 99.8% for AAA, and 99% for LEAD. In internal validation, 5.2% of the variable data were missing in Swissvasc, and 2.4% were different from data in patient records, resulting in external validity of 92.8% for carotids, 94.4% for AAA, and 90.1% for LEAD.

Conclusion: The VASCUNET template was used for international validation of registry data, and demonstrated that Swissvasc is a reliable system of quality data collection for the participating vascular centres, with excellent external validity and good internal validity. Quality in the Swissvasc registry data was clearly superior to local administrative data.

查看原文本刊更多论文

瑞士血管注册中心 Swissvasc 的国际验证：VASCUNET 报告。

目的：数据的有效性和完整性对登记数据至关重要，只有在每个国家的数据都是可靠的情况下，才能对国家间的差异做出有意义的解释。因此，VASCUNET 合作项目对多个血管登记数据进行了验证，目前已公布了瑞典、丹麦和马耳他国家血管登记数据的验证结果。本文介绍了瑞士血管登记处 Swissvasc Registry 的验证结果：方法：两名国际验证员访问了参与 Swissvasc 登记的 34 家医院中的 5 家。对颈动脉内膜剥脱术、肾下腹主动脉瘤（AAA）修复术和下肢动脉疾病（LEAD）搭桥手术进行了独立评估。为了进行外部验证，比较了当地的管理数据和瑞士血管登记处的数据；为了进行内部验证，比较了每组中随机抽取的15个病例的登记处数据和单个患者的病历数据：结果：医院管理数据确定了 265 例颈动脉、399 例 AAA 和 399 例 LEAD 手术，而 Swissvasc 确定了 265 例颈动脉、398 例 AAA 和 395 例 LEAD 手术。在医院管理数据中发现了四例 LEAD 手术，但在 Swissvasc 中未发现。颈动脉的外部有效性为 100%，AAA 为 99.8%，LEAD 为 99%。在内部验证中，Swissvasc中有5.2%的变量数据缺失，2.4%的数据与患者病历中的数据不同，因此颈动脉、AAA和LEAD的外部有效性分别为92.8%、94.4%和90.1%：结论：VASCUNET模板用于登记数据的国际验证，证明Swissvasc是一个可靠的系统，能为参与的血管中心收集高质量的数据，具有出色的外部有效性和良好的内部有效性。Swissvasc 登记数据的质量明显优于当地的行政数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Vascular and Endovascular Surgery 医学-外科

CiteScore

6.80

自引率

15.80%

发文量

471

审稿时长

66 days

期刊介绍： The European Journal of Vascular and Endovascular Surgery is aimed primarily at vascular surgeons dealing with patients with arterial, venous and lymphatic diseases. Contributions are included on the diagnosis, investigation and management of these vascular disorders. Papers that consider the technical aspects of vascular surgery are encouraged, and the journal includes invited state-of-the-art articles. Reflecting the increasing importance of endovascular techniques in the management of vascular diseases and the value of closer collaboration between the vascular surgeon and the vascular radiologist, the journal has now extended its scope to encompass the growing number of contributions from this exciting field. Articles describing endovascular method and their critical evaluation are included, as well as reports on the emerging technology associated with this field.